摘要
目的：探讨液基细胞技术在宫颈癌早期筛查中的应用价值。方法：对625例患者行TCT,用TBS诊断方法进行分析,对76例细胞学阳性及临床上高度可疑的50例共计126例患者行阴道镜检查,以评价TCT在临床上的应用价值,同时调查他们的疾病构成及年龄分布特征。结果：TBS诊断ASCUS40例,AGUS4例,ASC-H3例,LSIL18例,HSIL7例,SCC3例,AC1例。细胞学与阴道镜下活组织病理诊断符合率分别为LSIL72.22%,HSIL85.71%,SCC100%,76例患者中宫颈病变占4.64%,31~40岁的妇女为宫颈病变的最高发年龄段,占46.05%。结论：采用TCT技术对早期发现与治疗宫颈病变及宫颈癌有积极的临床作用。
Objective：To describe the value of Liquid-based cytology test （TCT） on early screening of cervical intraepithelial neoplasia.Method：The behesda system（TBS） was used to analyze the TCT of 625 patients.Colposcopy was performed on 126 cases,including 76 positive patients and 50 clinic highly questionable cases.So that to study the value of TCT in the clinical context and research the age distribution characteristics and clinical features of the patients.Result：According to TBS test,divide into：40 ASCUS,4 AGUS,3 ASC-H,18 LSIL,7 HSIL,3 SCC and 1 AC.The agreement rate of cytology and vaginal microscopically living tissue diagnosis in LSIL,HSIL and SCC each are 72.22%,85.71% and 100%.There are 4.64% cases in the 76 patents were with cervical intraepithelial neoplasia.The study shows that,females 31 to 40 years old are the higher age level of cervical intraepithelial neoplasia,about 46.05%.Conclusion：TCT are useful in early detection and treatment of cervical intraepithelial neoplasia.
出处
《中国医学创新》
CAS
2012年第31期77-78,共2页
Medical Innovation of China
关键词
液基细胞学
巴氏涂片
TBS诊断
宫颈病变
阴道镜活检
三阶梯诊断程序
Liquid based cytology test
Papanicolaou Smear
TBS diagnosis
Cervical intraepithelial neoplasia
Vaginal mirror biopsy
Three ladder diagnostic procedures
